FIZE Medical raises $5.8M for real-time renal monitoring platform

Funds from the round will be used to develop and commercialize the company’s iUO platform. The device is a cost-effective, automatic, digital device that gives healthcare providers access to real-time monitoring of urine output. The iUO device is the base model that FIZE Medical is developing, with the more advanced and feature-rich iUO PLUS and iUO DUOFLO giving providers new capabilities, inludingr acute kidney injury monitoring, shock prediction, and intraabdominal pressure monitoring (IAP). Key competitors in the patient monitoring devices market include Draeger, Philips, and the startup Potrero Medical (a presenting company at LSI’s 2021 Emerging Medtech Summit).

Moray Medical is developing a robotic delivery system for valve repair

Moray Medical’s goal is to simplify the delivery of vascular therapies via its robotics platform. The Coral System is the company’s first product, which combines robotic coordination, augmented reality (AR), and microfluidics into a device that enables transcatheter edge-to-edge repair of the mitral valve. Moray Medical recently announced the completion of its first round of funding, a Seed round which raised $5.7M. The robotic surgery market continues to propel forward as startups and major strategics like Intuitive Surgical, Auris Health (J&J) and Medtronic bring robotic solutions into the hands of surgeons.

SentiAR raises $5.1M from Series A round

The company is developing a fully-controllable, hands-free, augmented reality system for use during complex electrophysiology procedures for the treatment of cardiac arrhythmias. A 3D visualization of the patient’s actual anatomy is generated over the patient to provide clinicians with new insights, improve procedure accuracy, and shorten procedure times. To-date, SentiAR has raised approximately $15M in capital. The closing of the Series A round follows the news that SentiAR obtained FDA clearance for its CommandEP AR system in September 2020.

SentiAR is a presenting company at Life Science Intelligence’s 2021 Emerging Medtech Summit.

Memic Innovative Surgery begins commercialization of robot-assisted surgical system

In March 2021, the company received FDA De Novo Marketing Authorization for its Hominis surgical robotic system. The Hominis system is indicated for use in single-site, transvaginal benign surgical procedures, including hysterectomy. Beyond its initial indication for use, the company plans to pursue approval for use in general surgery and transluminal procedures. In April 2021, the company announced that it had completed a Series D funding round which raised an estimated $96M. Funds from the round will be used to advance commercialization of the Hominis Surgical System in the US and other countries.

Synergia Medical – utilizing optoelectronics for personalized neurostimulation

Synergia is looking to disrupt the neurostimulation market, which has traditionally relied on pacemaker-like devices and wire leads, with its fiber optic-based device that converts optical energy into electrical impulses. While the company’s technology could be used for the treatment of a wide-variety of neurological disorders, Synergia is prioritizing the treatment of epilepsy. According to the company, 30% of all epilepsy patients can not be treated with anti-epileptic drugs, creating a major unmet need and unique opportunity for neurostimulation technologies. Key strategics in the neuromodulation devices market include Abbott, Boston Scientific, and Neuropace.

Synergia Medical is a presenting company at Life Science Intelligence’s 2021 Emerging Medtech Summit.